FDA NDC Directory · JSON-LD · Markdown
NDC 68682-658 · HUMAN PRESCRIPTION DRUG · AEROSOL, FOAM
| Labeler / Manufacturer | Oceanside Pharmaceuticals |
|---|---|
| Marketing category | New Drug Application (innovator) · App NDA205613 |
| Dosage form / route | AEROSOL, FOAM · RECTAL |
| Active ingredients | BUDESONIDE (2 mg/1) |
| Marketing started | 20220715 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).